RecruitingPhase 4NCT07155070
Efficacy of Kera Sol Tears on Signs and Symptoms of Surgical Temporary Ocular Discomfort Syndrome (STODS) in Subjects Following LASIK
Kera Sol Post-LASIK: A Benefit Study
Sponsor
Vance Thompson Vision
Enrollment
60 participants
Start Date
Aug 1, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
Collecting data using Kera Sol tear usage during the initial two-week post-operative period after Laser-Assisted In Situ Keratomileusis (LASIK) has on the signs and symptoms of surgical temporary ocular discomfort syndrome (STODS)
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a drug called Kera Sol Eye Drops for people with dry eye. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGKera Sol Eye Drops
Eye drops
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07155070
Related Trials
The Effect of Rinsing on Ocular Inflammation and Symptoms in Patients With Dry Eye Disease
NCT076183641 location
Ocular Surface Health and Tear Film Stability With a Nasal Spray Dry Eye Treatment
NCT076066251 location
A Study to Evaluate the Performance and Safety of Artelac® Complete MDO® Versus VISMED® MULTI Eye Drops in the Management of Moderate to Severe Dry Eye Disease
NCT075938855 locations
Comparative Assessment of Lipid Layer Thickness Measurements
NCT075791301 location
Real-World Assessment of VEVYE® for Short-Term Symptom and Sign Improvement of Dry Eye Disease in a Neuro-Ophthalmology Clinic: A 6-Month Prospective Observational Study
NCT075669751 location